"Drug Utilization Review" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Formal programs for assessing drug prescription against some standard. Drug utilization review may consider clinical appropriateness, cost effectiveness, and, in some cases, outcomes. Review is usually retrospective, but some analysis may be done before drugs are dispensed (as in computer systems which advise physicians when prescriptions are entered). Drug utilization review is mandated for Medicaid programs beginning in 1993.
| Descriptor ID |
D017723
|
| MeSH Number(s) |
N04.452.706.477.400 N04.761.879.300 N05.700.900.300
|
| Concept/Terms |
Drug Utilization Review- Drug Utilization Review
- Evaluation, Drug Utilization
- Drug-Use Review
- Drug Use Review
- Drug-Use Reviews
- Reviews, Drug-Use
- Review, Drug Utilization
- Drug Utilization Reviews
- Reviews, Drug Utilization
- Utilization Reviews, Drug
- Utilization Review, Drug
- Drug Utilization Evaluation
- Drug Utilization Evaluations
- Evaluations, Drug Utilization
- Utilization Evaluation, Drug
- Utilization Evaluations, Drug
- Review, Drug-Use
- Review, Drug Use
|
Below are MeSH descriptors whose meaning is more general than "Drug Utilization Review".
Below are MeSH descriptors whose meaning is more specific than "Drug Utilization Review".
This graph shows the total number of publications written about "Drug Utilization Review" by people in this website by year, and whether "Drug Utilization Review" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1994 | 1 | 0 | 1 |
| 1996 | 1 | 0 | 1 |
| 1997 | 1 | 0 | 1 |
| 2003 | 0 | 1 | 1 |
| 2005 | 1 | 3 | 4 |
| 2012 | 1 | 0 | 1 |
| 2017 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Drug Utilization Review" by people in Profiles.
-
Lakhter V, Zack CJ, Brailovsky Y, Chatterjee S, Aggarwal V, Rao KA, Crabbe D, Zhao H, Choi E, Kolluri R, Bashir R. Sex differences in utilization and outcomes of catheter-directed thrombolysis in patients with proximal lower extremity deep venous thrombosis - Insights from the Nationwide Inpatient Sample. Vasc Med. 2017 04; 22(2):128-134.
-
Stefanacci RG. Financial oversight of medication use: an expanded role for consultant pharmacists. Consult Pharm. 2012 Apr; 27(4):290-5.
-
Zisselman MH, Smith RV, Smith SA, Daskalakis C, Sanchez F. Racial and socioeconomic differences in psychiatric symptoms in nursing home residents: a minimum data set-based pilot study. J Am Med Dir Assoc. 2006 Jan; 7(1):17-22.
-
Stefanacci RG. Strategies for developing a successful Medicare part D formulary. Manag Care. 2005 May; 14(5 Suppl):3-10.
-
Lindblad CI, Artz MB, Pieper CF, Sloane RJ, Hajjar ER, Ruby CM, Schmader KE, Hanlon JT. Potential drug-disease interactions in frail, hospitalized elderly veterans. Ann Pharmacother. 2005 Mar; 39(3):412-7.
-
Maio V, Pizzi L, Roumm AR, Clarke J, Goldfarb NI, Nash DB, Chess D. Pharmacy utilization and the Medicare Modernization Act. Milbank Q. 2005; 83(1):101-30.
-
Scott SD, Chrischilles EA, Link BK, Delgado DJ, Fridman M, Stolshek BS. Days of prophylactic filgrastim use to reduce febrile neutropenia in patients with non-Hodgkin's lymphoma treated with chemotherapy. J Manag Care Pharm. 2003 Mar-Apr; 9(2 Suppl):15-21.
-
Yuen EJ, Zisselman MH, Louis DZ, Rovner BW. Sedative-hypnotic use by the elderly: effects on hospital length of stay and costs. J Ment Health Adm. 1997; 24(1):90-7.
-
Zisselman MH, Rovner BW, Yuen EJ, Louis DZ. Sedative-hypnotic use and increased hospital stay and costs in older people. J Am Geriatr Soc. 1996 Nov; 44(11):1371-4.
-
Zisselman MH, Rovner BW, Kelly KG, Woods C. Benzodiazepine utilization in a university hospital. Am J Med Qual. 1994; 9(3):138-41.